FULC
Fulcrum Therapeutics Inc
3.70$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | -5,264.4% | -608.1% | -409.5% | -1,530.3% | -3,243.0% | -2.8% | – | |
| – | – | 273.7% | 27.0% | 13.1% | 38.1% | 77.4% | 2.0% | – | |
| – | – | 563.2% | 83.3% | 57.8% | 210.5% | 527.7% | 18.2% | – | |
| – | – | 3,975.3% | 83.3% | 57.8% | 210.5% | – | – | – | |
| – | – | 1,510.1% | 85.0% | -62.0% | -48.8% | -164.5% | -5.3% | – | |
| – | – | 113.7% | 15.2% | 8.9% | 31.0% | 18.1% | 0.3% | – | |
| – | – | -125.9% | -647.6% | -676.7% | 195.7% | -1,308.1% | 40.3% | – | |
| – | – | – | 776.6% | – | – | – | – | – | |
| – | – | -4.5% | -2.2% | 19.1% | -3.0% | – | – | – | |
| – | – | -6.0% | -0.6% | -0.1% | -0.8% | – | – | – | |
| – | – | 8,579.1% | 806.2% | 973.3% | 1,329.6% | 4,211.1% | 3.4% | – | |
| – | – | 3,188.8% | -449.5% | -112.9% | -5.0% | -339.9% | 40.9% | – | |
| – | – | -5,378.1% | -623.3% | -418.5% | -1,561.2% | -3,261.1% | -3.1% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.